Angiotensin Converting Enzyme (ACE) Inhibitors and Heart Failure
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 15 (6) , 535-550
- https://doi.org/10.2165/00019053-199915060-00002
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- The use of HMG Co-A reductase inhibitors following acute myocardial infarction in hospital practicePublished by Oxford University Press (OUP) ,1998
- The Economics of TRACEPharmacoEconomics, 1998
- Cost-Effectiveness Analysis of Early Lisinopril Use in Patients With Acute Myocardial InfarctionPharmacoEconomics, 1998
- An Economic Analysis of the Survival and Ventricular Enlargement (SAVE) StudyPharmacoEconomics, 1997
- The use of angiotensin-converting enzyme inhibitors in the treatment of heart failure in hospital practicePublished by Oxford University Press (OUP) ,1997
- The Pharmacoeconomics of ACE Inhibitors in Chronic Heart FailurePharmacoEconomics, 1996
- Heart FailurePharmacoEconomics, 1996
- Effects of ACE Inhibitors on Heart Failure in The NetherlandsPharmacoEconomics, 1993
- Costs and Effectiveness of Routine Therapy with Long-Term Beta-Adrenergic Antagonists after Acute Myocardial InfarctionNew England Journal of Medicine, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987